Excellent post fuzzy.

I still believe that even if an actual donkey (or version there of) was appointed COB, CEO and President of RVX if the Covid trial is a huge success even the donkey that is power now won't be able to hold the share price back...I hope     :)  .

We've seen that good science with no business benchstrength (biotech business experience, biotech financing and brand building (marketing, public relations, online presence)) leads to a share price fo $0.60 but a success with covid will be swooped up by the press.

I'm long on science.

GLTA

Toinv